IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v17y2020i17p6378-d407500.html
   My bibliography  Save this article

Patient-Perceived Benefit of Treatment in Polypoidal Choroidal Vasculopathy: A Pilot Study

Author

Listed:
  • Rituparna Ghoshal

    (Optometry and Vision Science Program, Faculty of Health Sciences, University Kebangsaan Malaysia, Kuala Lumpur 50300, Malaysia
    Department of Optometry, Supreme Institute of Management and Technology, Mankundu Hooghly, West Bengal 712123, India)

  • Sharanjeet Sharanjeet-Kaur

    (Optometry and Vision Science Program, Faculty of Health Sciences, University Kebangsaan Malaysia, Kuala Lumpur 50300, Malaysia)

  • Norliza Mohamad Fadzil

    (Optometry and Vision Science Program, Faculty of Health Sciences, University Kebangsaan Malaysia, Kuala Lumpur 50300, Malaysia)

  • Somnath Ghosh

    (Department of Allied Health Sciences, Brainware University, Barasat, Kalkata, West Bengal 700125, India)

  • Nor Fariza Ngah

    (Department of Ophthalmology, Hospital Shah Alam, Persiaran Kayangan, Seksyen 7, Shah Alam 40000, Selangor, Malaysia)

  • Roslin Azni Abd Aziz

    (Department of Ophthalmology, Hospital Shah Alam, Persiaran Kayangan, Seksyen 7, Shah Alam 40000, Selangor, Malaysia)

Abstract

Polypoidal choroidal vasculopathy (PCV), a subtype of neovascular age-related macular degeneration, requires repeated treatment. The objective of this pilot study was to evaluate and compare vision-targeted quality of life (QOL) at baseline and after 6 months of treatment in patients with PCV. Naive PCV patients were recruited. Visual functions assessed were distance visual acuity (DVA), near visual acuity (NVA), contrast sensitivity (CS), reading speed (RS), and QOL at baseline and after 6 months of treatment. Thirty patients (average age of 67.62 ± 8.05 years) revealed mean DVA and NVA improvements of 0.24 logMAR and 0.30 logMAR, respectively. Mean CS and RS improved by 0.39 log contrast and 25.58 words per minute, respectively. The National Eye Institute Visual Function Questionnaire 25 (NEI-VFQ-25) composite score significantly increased from a baseline of 66.73 ± 13.74 to 73.54 ± 14.26. Twenty-eight of the patients showed overall improvement in QOL score by 5 units or more or remained stable. Subscales of NEI-VFQ-25 significantly improved, with general vision, mental health, and role difficulties improving by 10 or more units. The present pilot study reports a significant improvement of QOL in PCV patients after 6 months of treatment, with mental health, role difficulties, social functioning, and distance vision activities being the most improved subscales.

Suggested Citation

  • Rituparna Ghoshal & Sharanjeet Sharanjeet-Kaur & Norliza Mohamad Fadzil & Somnath Ghosh & Nor Fariza Ngah & Roslin Azni Abd Aziz, 2020. "Patient-Perceived Benefit of Treatment in Polypoidal Choroidal Vasculopathy: A Pilot Study," IJERPH, MDPI, vol. 17(17), pages 1-9, September.
    • Handle: RePEc:gam:jijerp:v:17:y:2020:i:17:p:6378-:d:407500
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/17/17/6378/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/17/17/6378/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Hannah Weyer-Wendl & Peter Walter, 2016. "Financial burden and quality of life of informal caregivers of patients with wet age-related macular degeneration," Health Economics Review, Springer, vol. 6(1), pages 1-10, December.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Rituparna Ghoshal & Sharanjeet Sharanjeet-Kaur & Norliza Mohamad Fadzil & Somnath Ghosh & NorFariza Ngah & Roslin Azni Abd Aziz, 2021. "Baseline Optical Coherence Tomography Parameters That May Influence 6 Months Treatment Outcome of Polypoidal Choroidal Vasculopathy Eyes with Combination Therapy: A Short-Term Pilot Study," IJERPH, MDPI, vol. 18(10), pages 1-9, May.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.

      Corrections

      All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:17:y:2020:i:17:p:6378-:d:407500. See general information about how to correct material in RePEc.

      If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

      If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

      If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

      For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

      Please note that corrections may take a couple of weeks to filter through the various RePEc services.

      IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.